HHeadlines Read More NLS Pharmaceutics, Kadimastem Sign MOU on Gene-Edited TherapiesOctober 27, 2025 The collaboration will progress under the combined company, NewCelX, upon completion of the anticipated merger ZURICH and NESSÂ ZIONA,…